Overview

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to test the safety and the effects of using an investigational drug regimen; once daily ABT-335 (Investigational drug) administered in combination with once daily atorvastatin calcium, rosuvastatin calcium or simvastatin in patients with abnormal lipid levels in the blood.

Phase:

Phase 3

Details

Lead Sponsor:

Abbott

Treatments:

Atorvastatin
Atorvastatin Calcium
Calcium
Calcium, Dietary
Fenofibrate
Rosuvastatin Calcium
Simvastatin